'Drugs Made In America' SPAC Eyes $1B Deal With AI Platform
Special purpose acquisition company Drugs Made In America Acquisition Corp. has filed plans with U.S. regulators to merge with tech company Power Analytics Global Corp. in a deal with a target...To view the full article, register now.
Already a subscriber? Click here to view full article